Impact of COVID-19 Health Policies on Other Infectious Diseases
Guest edited by Carlo Torti, Elijah Paintsil and Peter Nyasulu.
Collections open to submissions
Editor´s Picks
Articles
-
-
Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins
-
Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case–control study
-
Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019
-
Issues with reporting and interpretation of Khan et al. 2021
The Research article to this article has been published in BMC Infectious Diseases 2021 21:1014
-
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
-
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
The Correction to this article has been published in BMC Infectious Diseases 2021 21:436
-
Case report of restless anal syndrome as restless legs syndrome variant after COVID-19
-
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
-
Timing of progression from Chlamydia trachomatisinfection to pelvic inflammatory disease: a mathematical modelling study
Aims and scope
BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Editorial Board Updates
We are Recruiting new Editorial Board Members
We are recruiting new, international Editorial Board Members.
Meet Gerald Mboowa
Meet our Editorial Board Member working on the Sustainable Development Goals.
Featured
SARS-CoV-2 and COVID-19
Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.
Equity in academic publishing
for authors based in low- and middle-income countries who might face challenges in publishing their work. Follow us for guidance on submitting your research to us.
BMC Series Blog
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Annual Journal Metrics
-
Citation Impact
3.090 - 2-year Impact Factor
3.401 - 5-year Impact Factor
1.581 - Source Normalized Impact per Paper (SNIP)
1.278 - SCImago Journal Rank (SJR)Speed
24 days to first decision for all manuscripts
78 days to first decision for reviewed manuscripts only
184 days from submission to acceptance
14 days from acceptance to publicationUsage
14,215,125 Downloads (2021)
4,959 Altmetric Mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication